Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bioxyne Limited ( (AU:BXN) ) just unveiled an announcement.
Bioxyne Limited has informed the ASX that it is cancelling a previously lodged notice relating to the cessation of certain securities. The company clarified that an earlier Appendix 3H filed on 19 December 2024, which recorded the lapsing of 10,333,334 performance rights, had already been included in a subsequent Appendix 3H lodged on 22 March 2024, prompting the formal cancellation of the redundant December filing as of 16 January 2026.
The most recent analyst rating on (AU:BXN) stock is a Buy with a A$0.04 price target. To see the full list of analyst forecasts on Bioxyne Limited stock, see the AU:BXN Stock Forecast page.
More about Bioxyne Limited
Average Trading Volume: 1,649,555
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$82.34M
For detailed information about BXN stock, go to TipRanks’ Stock Analysis page.